| Inflammatory process in Alzheimer’s and Parkinson's diseases: central role of cytokines Q Alam, M Zubair Alam, G Mushtaq, G A Damanhouri, M Rasool, ... Current pharmaceutical design 22 (5), 541-548, 2016 | 228 | 2016 |
| A synopsis on the role of tyrosine hydroxylase in Parkinson's disease S Tabrez, N R Jabir, S Shakil, N H Greig, Q Alam, A M Abuzenadah, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2012 | 175 | 2012 |
| Cancer chemoprevention by polyphenols and their potential application as nanomedicine S Tabrez, M Priyadarshini, M Urooj, S Shakil, GM Ashraf, MS Khan, ... Journal of Environmental Science and Health, Part C 31 (1), 67-98, 2013 | 97 | 2013 |
| New Delhi metallo-β-lactamase (NDM-1): An updates S Shakil, EI Azhar, S Tabrez, MA Kamal, NR Jabir, AM Abuzenadah, ... Journal of Chemotherapy 23 (5), 263-265, 2011 | 72 | 2011 |
| Current progress on peroxisome proliferator-activated receptor gamma agonist as an emerging therapeutic approach for the treatment of Alzheimer's disease: an update MA Khan, Q Alam, A Haque, M Ashafaq, MJ Khan, GM Ashraf, M Ahmad Current Neuropharmacology 17 (3), 232-246, 2019 | 68 | 2019 |
| Candida identification: a journey from conventional to molecular methods in medical mycology MZ Alam, Q Alam, A Jiman-Fatani, MA Kamal, AM Abuzenadah, ... World Journal of Microbiology and Biotechnology 30, 1437-1451, 2014 | 68 | 2014 |
| A possible link of gut microbiota alteration in type 2 diabetes and Alzheimer’s disease pathogenicity: an update M Z Alam, Q Alam, M A Kamal, A M Abuzenadah, A Haque CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 62 | 2014 |
| Next-generation sequencing-based pre-implantation genetic testing for aneuploidy (PGT-A): First report from Saudi Arabia Y Alyafee, Q Alam, AA Tuwaijri, M Umair, S Haddad, M Alharbi, ... Genes 12 (4), 461, 2021 | 42 | 2021 |
| Current understanding of HSP90 as a novel therapeutic target: an emerging approach for the treatment of cancer A Haque, Q Alam, M Zubair Alam, E I Azhar, K Hussain Wali Sait, ... Current pharmaceutical design 22 (20), 2947-2959, 2016 | 41 | 2016 |
| A nanotechnological approach to the management of Alzheimer disease and type 2 diabetes Q Alam, M ZubairAlam, S Karim, S H Gan, M A Kamal, A Jiman-Fatani, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 38 | 2014 |
| Microneedles drug delivery systems for treatment of cancer: A recent update AA Seetharam, H Choudhry, MA Bakhrebah, WH Abdulaal, MS Gupta, ... Pharmaceutics 12 (11), 1101, 2020 | 36 | 2020 |
| Non-invasive prenatal testing for autosomal recessive disorders: A new promising approach Y Alyafee, A Al Tuwaijri, M Umair, M Alharbi, S Haddad, M Ballow, ... Frontiers in Genetics 13, 1047474, 2022 | 34 | 2022 |
| Next generation sequencing based non-invasive prenatal testing (NIPT): First report from Saudi Arabia Y Alyafee, A Al Tuwaijri, Q Alam, M Umair, S Haddad, M Alharbi, M Ballow, ... Frontiers in Genetics 12, 630787, 2021 | 33 | 2021 |
| A brief overview of tyrosine hydroxylase and α-synuclein in the Parkinsonian brain W Khan, M Priyadarshini, H A Zakai, M A Kamal, Q Alam CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2012 | 31 | 2012 |
| Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and other coronaviruses: a genome-wide comparative annotation and analysis M Tarique, S Ahmad, A Malik, I Ahmad, M Saeed, A Almatroudi, T Qadah, ... Molecular and Cellular Biochemistry 476, 2203-2217, 2021 | 28 | 2021 |
| Interaction of human brain acetylcholinesterase with cyclophosphamide: a molecular modeling and docking study S Shakil, R Khan, S Tabrez, Q Alam, N R Jabir, M I Sulaiman, N H Greig, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2011 | 28 | 2011 |
| Translational shift of HSP90 as a novel therapeutic target from cancer to neurodegenerative disorders: an emerging trend in the cure of Alzheimer's and Parkinson's diseases Q Alam, M Zubair Alam, K Hussain Wali Sait, N Anfinan, ... Current Drug Metabolism 18 (9), 868-876, 2017 | 26 | 2017 |
| A molecular bridge: connecting type 2 diabetes and Alzheimer’s disease F Ahmed, J Asghar Ansari, Z Eqbal Ansari, Q Alam, S Hua Gan, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 26 | 2014 |
| Infectious agents and neurodegenerative diseases: exploring the links M Zubair Alam, Q Alam, M Amjad Kamal, A Ahmad Jiman-Fatani, ... Current topics in medicinal chemistry 17 (12), 1390-1399, 2017 | 25 | 2017 |
| Biallelic variant in DACH1, encoding Dachshund Homolog 1, defines a novel candidate locus for recessive postaxial polydactyly type A M Umair, O Palander, M Bilal, B Almuzzaini, Q Alam, F Ahmad, M Younus, ... Genomics 113 (4), 2495-2502, 2021 | 23 | 2021 |
